Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission

Background Subsequent risk of hepatocellular carcinoma (HCC) persists in chronic hepatitis B (CHB) patients with virological remission. We aimed to assess the cost-effectiveness of HCC surveillance in those patients and determine appropriate age to commence or discontinue surveillance. Methods We de...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC public health Jg. 24; H. 1; S. 2202 - 12
Hauptverfasser:	Fang, Kailu, Li, Shuwen, Lin, Yushi, Zhang, Yu, Wu, Jie
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 13.08.2024 BioMed Central Ltd Springer Nature B.V BMC
Schlagworte:	Ablation Adult Age Aged Barriers and facilitators to cancer screening Biostatistics Cancer Cancer therapies Carcinoma, Hepatocellular Care and treatment China - epidemiology Cirrhosis Cohort analysis Cost analysis Cost benefit analysis Cost effectiveness Development and progression Diagnosis Economic aspects Economics Environmental Health Epidemiology Female Fibrosis Hepatitis Hepatitis B Hepatitis B, Chronic - complications Hepatocellular carcinoma Hepatoma Humans Immunization Liver Liver cancer Liver cirrhosis Liver Cirrhosis - complications Liver diseases Liver Neoplasms Liver transplants Magnetic resonance imaging Male Medical prognosis Medicine Medicine & Public Health Methods Microsimulation modeling Middle Aged Patients Public Health Quality-Adjusted Life Years Radiation therapy Remission Remission (Medicine) Risk factors Risk groups Screening Simulation Surveillance Vaccine China United States > US Liver cancer Screening Microsimulation modeling Cost-effectiveness
ISSN:	1471-2458, 1471-2458
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!